|
|
41
|
0541E
|
BLEOMYCIN SULPHATE 15MG INJ (KWA) (BQ)
|
BLEOMYCIN SULPHATE
|
BLEOMYCIN SULPHATE
|
15MG VIAL
|
BQ
|
34.01
|
34.0062
|
VIAL
|
30
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
40
|
05616
|
CHLORAMBUCIL 2MG TAB (KWA/ATB)
|
CHLORAMBUCIL
|
CHLORAMBUCIL
|
3X10
|
A
|
176.69
|
5.89
|
TABLET
|
240
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-05-27
|
2024-03-31
|
Package Size Change
|
Oral
|
6
|
ANTINEOPLASTICS
|
2022-05-27
|
|
|
40
|
05743
|
ENDOXAN 50MG TAB (BAX/STO) CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
50'S
|
B
|
0.95
|
0.02
|
TABLET
|
0
|
TAB
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
41
|
05743
|
ENDOXAN 50MG TAB (BAX) CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
50'S
|
A
|
1.33
|
0.0266
|
TAB
|
240
|
BOX
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
40
|
05752
|
ENDOXAN 1G INJ (ASM/COL) CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
1G VIAL
|
BQ
|
38.06
|
38.06
|
INJECTION
|
0
|
VIAL
|
ASM
|
ASTA MEDICA AG
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
05756
|
ENDOXAN 1G INJ (BAX/STO) CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
1G VIAL
|
BQ
|
15.96
|
15.96
|
INJECTION
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
41
|
05756
|
ENDOXAN 1G INJ (BAX) CYCLOPHOSPHAMIDE (BQ)
|
CYCLOPHOSPHAMIDE
|
ENDOXAN
|
1G VIAL
|
BQ
|
17.34
|
17.3429
|
VIAL
|
30
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
41
|
0575F
|
CYCLOPHOSPHAMIDE 1G INJ (KWA) (BQ)
|
CYCLOPHOSPHAMIDE
|
CYCLOPHOSPHAMIDE
|
1G VIAL
|
BQ
|
10.41
|
10.4112
|
VIAL
|
30
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
41
|
05814
|
CYTARABINE 100MG INJ (ZUV) (BQ)
|
CYTARABINE
|
CYTARABINE
|
100MG VIAL
|
BQ
|
7.48
|
7.4754
|
VIAL
|
100
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
INJ
|
6
|
ANTINEOPLASTICS
|
|
|
|
41
|
0581D
|
CYTARABINE 100MG INJ (KWA) (BQ)
|
CYTARABINE
|
CYTARABINE
|
100MG VIAL
|
BQ
|
5.55
|
5.5454
|
VIAL
|
100
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
40
|
0582B
|
CYTARABINE 1G INJ (INP/AHI)
|
CYTARABINE
|
CYTARABINE
|
1G VIAL
|
BQ
|
38.46
|
38.46
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
0582D
|
ONCOTAR 1G INJ (UBI/RXP) CYTARABINE
|
CYTARABINE
|
ONCOTAR
|
1G VIAL
|
BQ
|
31.26
|
31.26
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
41
|
0582E
|
CYTRAZ 1G INJ (ZUV) CYTARABINE (BQ)
|
CYTARABINE
|
CYTRAZ
|
1G VIAL
|
BQ
|
20.69
|
20.6864
|
VIAL
|
0
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
06032
|
FLUOROURACIL 50MG/ML INJ (EBA/COL)
|
FLUOROURACIL
|
FLUOROURACIL
|
10ML
|
BQ
|
26.48
|
26.48
|
INJECTION
|
0
|
VIAL
|
EBA
|
EBEW ARZNEIMITTLE GES.MBH
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
41
|
0603B
|
FLUOROURACIL 50MG/ML INJ (DIL) (BQ)
|
FLUOROURACIL
|
FLUOROURACIL
|
10X10ML
|
BQ
|
126.97
|
12.6973
|
VIAL
|
0
|
BOX
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
41
|
0603D
|
FLUOROURACIL 50MG/ML INJ (SLS (BQ)
|
FLUOROURACIL
|
FLUOROURACIL
|
10ML
|
BQ
|
18.67
|
18.6749
|
VIAL
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
40
|
0611B
|
MELPHALAN 2MG TAB (TPP/AHI)
|
MELPHALAN
|
MELPHALAN
|
50'S
|
A
|
75.05
|
1.50
|
TABLET
|
63
|
TAB
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
41
|
0611C
|
MELPHALAN 2MG TAB (KWA)
|
MELPHALAN
|
MELPHALAN
|
50'S
|
A
|
83.18
|
1.6636
|
TAB
|
63
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
40
|
0621B
|
MERCAPTOPURINE 50MG TAB (SLS/AHI)
|
MERCAPTOPURINE
|
MERCAPTOPURINE
|
30'S
|
A
|
45.64
|
1.52
|
TABLET
|
60
|
TAB
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
41
|
0621B
|
MERCAPTOPURINE 50MG TAB (SLS)
|
MERCAPTOPURINE
|
MERCAPTOPURINE
|
30'S
|
A
|
45.64
|
1.5214
|
TAB
|
60
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|